Akums Drugs and Pharmaceuticals Limited

₹743.80As of Sun 8 Nov 2026, 12:00 UTC
NSE:AKUMSHealthcare
Country India
PE (Fwd) •••
TSR 2Y CAGR (6.42%)
Div yield 0.13%
ROE 10.90%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.62
PE TTM 31.31
TSR TTM 62.20%
Mkt cap ₹113.9B
ROIC 18.87%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹712
(4.30%)
181.32%
Hold 7|3|4|10|3
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
6.75
6.77
6.75
7.06
(1.42%)
(5.58%)
(5.73%)
2.21%
Revenue₹B
11.81
12.28
12.94
12.71
6.87%
9.13%
17.30%
12.06%
Peers (US$1.194B)
Cap (US$)
PE
1.414B
70.86x
1.079B
48.36x
Capital
TTM
5Y
10Y
Leveragex
0.713
0.223
0.158
EBIT/Intx
0.297
0.077
0.069
Own earn%
358.68
207.46
207.18
Sh yield%
28.91
13.16
14.03
Owners
Insiders/Inst%
12.09
35.28
Short interest%
4.07
SBC / revenue%
1.13
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
0–3
$1 testx
—
Incr. ROIC%
2